Arkolith/Insider Trading/ONCY/Form 4

Aromando Andrew

Chief Business OfficerONCOLYTICS BIOTECH INC (ONCY) · full profile →Form 4 · filed Feb 13, 2026
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2026Buy(P)30K$0.86$25K55K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-006541) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML